Sever Pharma Solutions Celebrates 50 years of Pharmaceutical Innovation
Sever Pharma Solutions, a leading Contract Development and Manufacturing Organization (CDMO) specializing in controlled release drug delivery systems for high-potent drugs, is proud to celebrate its 50th anniversary this year. The milestone marks five decades of innovation, expertise, and partnership in pharmaceutical development and manufacturing.
Founded in 1975 as a pharmaceutical facility under Ferrosan in Malmö, Sweden, the company has undergone several strategic transformations over the decades. In 2021, it rebranded as Sever Pharma Solutions, ushering in a new era of global expansion. Today, Sever operates from state-of-the-art facilities in Malmö, Sweden, and Putnam, Connecticut, USA, delivering advanced development and manufacturing solutions to customers worldwide.
“Reaching 50 years is an incredible milestone. It reflects the dedication, expertise, and collaboration that have defined our journey. We are proud of our heritage and even more excited about the future – continuing to drive innovation with our partners,” says Fredrik Hultenius, CEO of Sever Pharma Solutions.
Sever Pharma Solutions is one of the few CDMOs specializing in controlled-release systems for highly potent drugs, offering a comprehensive range of CDMO services that support drug product development from start to finish. The expertise includes polymer-based delivery systems, highly potent compounds (up to OEB6), hormonal and controlled DEA substances (Schedule 3–5), with proven experience in developing complex drug delivery systems such as
implants and vaginal rings.
“As we honor our company’s legacy, our sights are set firmly on the future. We remain committed to delivering value, precision, and cutting-edge high-potent drug delivery solutions that positively impact patients in the global environment,” says Ulrike Foley, Head of Global Business Development and Marketing.
Total Page Views: 128
